We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Device Products » The Correction and Removals Guidance - Webinar CD/Transcript

Other Options

Audio CD/Transcript - Jan. 19, 2017

$287.00

Audio CD/Transcript - Jan. 19, 2017

$258.00

Audio CD/Transcript - Jan. 19, 2017

$244.00

Audio CD/Transcript - Jan. 19, 2017

$230.00

Audio CD/Transcript - Jan. 19, 2017

$215.00

The Correction and Removals Guidance - Webinar CD/Transcript

$287.00
Device Products

Product Details

The Correction and Removals Guidance: Understanding and Implementation

It’s been two years since the guidance was published and device manufacturers are still confused about what to do when it comes to corrections and removals.

Corrections and removals are intertwined  with design changes, device improvements and recalls.

How can you tell the differences between a device enhancement — which is not reported to the FDA — a reportable activity and reporting exceptions?

Understanding the definitions is hard enough…  but when those definitions don’t agree across the various applicable regulations you need help.

Join industry expert Dan O’Leary for an in-depth explanation. Dan will start with the difference between an enhancement and a reportable change — a change the FDA would classify as a recall. Then, he’ll clarify which changes are not reportable. He’ll explain these ideas using examples, warning letters and recalls.

After attending this 90-minute session you will understand:

  • The requirements of Part 806
  • The difference between a correction and a removal and how to report them
  • The exceptions in Part 806 and how to apply them to make the reporting decision
  • What an investigator will look for in a QSIT inspection
  • What to look for in an effective program
  • The observations in warning letters and how you can avoid the same mistakes
  • How to make design changes and when you need to update a 510(k)

BONUS MATERIALS — All attendees will receive the following materials to help implement the regulations:

  • A copy of the final guidance document
  • A copy of the Corrections and Removal regulation, formatted for easier reading
  • An Excel spreadsheet that will help you determine if the event is reportable
  • A comparative analysis of the definitions in the Recall regulation (Part 7) and the Correction & Removal regulation (Part 806)

Order today and gain a better understanding of how your records and reporting relate to corrections and removal.

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing